Trump Plans To Sign Executive Order On The Psychedelic Ibogaine As Soon As This Week …
Ibogaine opioid use disorder treatment is gaining attention with Trump's upcoming executive order. This psychedelic shows promise but carries cardiac safety risks. Clinical oversight is essential for safe access and effective policy.
Mapping Public Attitudes Toward Psychedelics: Insight from the RAND Study – Drug Science
Understanding public attitudes toward psychedelics is crucial for advancing clinical implementation and patient access. The RAND study provides valuable insights into societal perceptions of psychedelic therapies. These attitudes influence policy…
Hawaii Lawmakers Approve Bill To Create Psychedelics Task Force
Hawaii lawmakers have approved a bill to create a psychedelics task force study focused on psilocybin and MDMA. This task force will examine therapeutic applications and regulatory considerations. The study reflects growing interest in psychedelic…
Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin mushrooms regulation is lagging behind their mainstream adoption, creating clinical risks. Scientific research on psilocybin remains limited, complicating safe patient care. Clinicians must navigate drug interactions and screening to ensure…
Scientists Gene Hacked a Plant to Produce Multiple Psychoactive Drugs
This article highlights biotechnology research psychedelics involving gene-hacked plants that produce multiple psychoactive compounds. The development may improve production consistency and cost-effectiveness. While promising, these compounds remain…
Brain Scans Reveal Voluntary Psychedelic-Like Trance Without Drugs
This neuroimaging study drug-free altered states reveals how a woman voluntarily enters a psychedelic-like trance without drugs. The research highlights specific brain activity patterns during these altered states. Understanding these mechanisms may…
Missouri Bill Would Allow Clinical Trials on Psychedelic Therapy for Veterans, First Responders
Missouri's new bill enables psychedelic-assisted therapy clinical trials specifically for veterans and first responders. These clinical trials aim to generate rigorous safety and efficacy data. Psychedelic-assisted therapy clinical trials represent a…
Texas to Conduct Its Own Ibogaine Clinical Trials – Clinical Insights
Texas ibogaine clinical trials mark a pivotal step in state-level psychedelic research. These trials focus on addiction treatment potential while addressing cardiac safety concerns. This initiative highlights Texas's leadership in advancing alternative…
Texas Launches State-Sponsored Psychedelic Research with Ibogaine Trials
Texas is pioneering state-sponsored psychedelic research by initiating ibogaine clinical trials for addiction treatment. This approach represents a significant shift in regulatory pathways at the state level. State-sponsored psychedelic research could…
New Funding Enables Psychedelic Therapy Safety Tracking in Colorado
New funding enables psychedelic therapy safety tracking in Colorado to monitor adverse events and usage patterns. This initiative provides critical real-world data for patient safety. It supports clinical research and informs therapeutic guidelines.